These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 31798214)
41. Is microwave ablation more effective than radiofrequency ablation in achieving local control for primary pulmonary malignancy? Tsakok MT; Jones D; MacNeill A; Gleeson FV Interact Cardiovasc Thorac Surg; 2019 Aug; 29(2):283–286. PubMed ID: 30929016 [TBL] [Abstract][Full Text] [Related]
42. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer. Bibok A; Kim DW; Malafa M; Kis B World J Gastroenterol; 2021 Jul; 27(27):4322-4341. PubMed ID: 34366607 [TBL] [Abstract][Full Text] [Related]
44. Radiofrequency ablation and breast cancer: a review. Nguyen T; Hattery E; Khatri VP Gland Surg; 2014 May; 3(2):128-35. PubMed ID: 25083506 [TBL] [Abstract][Full Text] [Related]
45. Differences in patterns of care: reablation and nephrectomy rates after needle ablative therapy for renal masses stratified by medical specialty. Long L; Park S J Endourol; 2009 Mar; 23(3):421-6. PubMed ID: 19260799 [TBL] [Abstract][Full Text] [Related]
46. Ultrasound-guided ablative therapy for hepatic malignancies : a comparison of the therapeutic effects of microwave and radiofrequency ablation. Zhang XG; Zhang ZL; Hu SY; Wang YL Acta Chir Belg; 2014; 114(1):40-5. PubMed ID: 24720137 [TBL] [Abstract][Full Text] [Related]
47. Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors. Ansari D; Andersson R World J Gastroenterol; 2012 Mar; 18(10):1003-8. PubMed ID: 22416173 [TBL] [Abstract][Full Text] [Related]
48. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers. Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166 [TBL] [Abstract][Full Text] [Related]
49. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis. Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733 [TBL] [Abstract][Full Text] [Related]
51. Minimally invasive ablative techniques in the treatment of breast cancer: a systematic review and meta-analysis. Peek MCL; Ahmed M; Napoli A; Usiskin S; Baker R; Douek M Int J Hyperthermia; 2017 Mar; 33(2):191-202. PubMed ID: 27575566 [TBL] [Abstract][Full Text] [Related]
52. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357 [TBL] [Abstract][Full Text] [Related]
53. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration. Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137 [TBL] [Abstract][Full Text] [Related]
55. Microwave ablation: How we do it? Gala KB; Shetty NS; Patel P; Kulkarni SS Indian J Radiol Imaging; 2020; 30(2):206-213. PubMed ID: 33100690 [TBL] [Abstract][Full Text] [Related]
56. Local ablative treatments for hepatocellular carcinoma: An updated review. Facciorusso A; Serviddio G; Muscatiello N World J Gastrointest Pharmacol Ther; 2016 Nov; 7(4):477-489. PubMed ID: 27867681 [TBL] [Abstract][Full Text] [Related]
57. Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer. Ito K; Soga S; Seguchi K; Shinchi Y; Masunaga A; Tasaki S; Kuroda K; Sato A; Asakuma J; Horiguchi A; Shinmoto H; Kaji T; Asano T Oncol Lett; 2017 Jul; 14(1):918-924. PubMed ID: 28693252 [TBL] [Abstract][Full Text] [Related]
58. Radiofrequency ablation for the treatment of small renal masses: safety and oncologic efficacy. Joniau S; Tsivian M; Gontero P Minerva Urol Nefrol; 2011 Sep; 63(3):227-36. PubMed ID: 21993321 [TBL] [Abstract][Full Text] [Related]